Zepbound Now Available Through Hims & Hers

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.

The company said Tuesday it now provides access to Zepbound, a brand-name version of the drug tirzepatide, as well as to generic liraglutide.

Zepbound is made by drugmaker Eli Lilly. While Hims & Hers of...

More Americans Can't Afford Health Care, Prescriptions

The inability to pay for health care has reached a new high in the United States, a new study says.

More than one-third of Americans — an estimated 91 million people — say they couldn't afford to access quality health care if they needed it today, according to the latest West Health-Gallup Healthcare Affordability Index.

...

Swallowing Disorder Not Widely Known, Understood By Public

Insomnia and vertigo are health conditions so well-known that movies have been named after them.

But only a quarter of Americans know about a condition that occurs even more often than vertigo or insomnia, called dysphagia, a new study says.

Dysphagia is a condition in which people have trouble swallowing, due to nerve, muscle or str...

Drug Overdose Deaths Rising Faster in Black Americans, Study Finds

Black Americans have been dying from drug overdoses (OD) at higher rates than white Americans, a new study says.

Both Black men and women are at greater risk of a fatal OD compared to white people, researchers reported April 1 in JAMA Network Open.

The OD death rate for Black men surpassed the rate for white men in 2016, and...

Eye Exam Can Assess Risk Of Delirium Following Surgery

They say the eyes are the windows to the soul.

The eyes also might help detect seniors at risk for a common syndrome in which they emerge from surgery in a state of delirium, new research suggests.

Seniors who have thicker retinas are about 60% more likely to develop post-surgical delirium, researchers reported April 1 in the journal...

Low 'Bad' Cholesterol Might Protect Against Dementia, Alzheimer's

Lower levels of “bad” LDL cholesterol could mean a lower risk of dementia and Alzheimer’s disease, a new study says.

People with low-density lipoprotein (LDL) cholesterol levels lower than 70 mg/dl had a 26% lower risk of dementia and 28% lower risk of Alzheimer’s, compared to people with LDL levels above 130 mg/dl,...